Literature DB >> 26497791

Lymphatic drainage from the eye: A new target for therapy.

Yeni Yucel1, Neeru Gupta2.   

Abstract

Lowering intraocular pressure (IOP) has been central to glaucoma care for over a century. In order to prevent sight loss from disease, there has been considerable focus on medical and surgical methods to improve fluid drainage from the eye. In spite of this, our understanding of exactly how aqueous humor leaves the eye is not complete. Recently, lymphatic vessels have been discovered in the human uvea, with studies showing lymphatic fluid outflow in several models, in addition to evidence for their pharmacological enhancement. The presence of a lymphatic outflow system points to an exciting, expanded understanding of how fluid and particulate materials such as proteins move out of the eye, and how IOP may be regulated. We coin the term "uveolymphatic pathway"-to reflect a comprehensive and compelling new target for glaucoma and an exciting opportunity for future investigations to better understand the eye in health and disease.
© 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Aqueous humor; Conventional outflow; Drainage; Eye; Glaucoma; Intraocular pressure; Lymphatic outflow; Trabecular meshwork; Uveolymphatic pathway; Uveoscleral outflow

Mesh:

Year:  2015        PMID: 26497791     DOI: 10.1016/bs.pbr.2015.07.028

Source DB:  PubMed          Journal:  Prog Brain Res        ISSN: 0079-6123            Impact factor:   2.453


  9 in total

1.  Quantitative imaging of the clearance systems in the eye and the brain.

Authors:  Wenyu Deng; Crystal Liu; Carlos Parra; Jeffrey R Sims; Muneeb A Faiq; Anoop Sainulabdeen; Hana Song; Kevin C Chan
Journal:  Quant Imaging Med Surg       Date:  2020-01

Review 2.  Unraveling the Possible Routes of SARS-COV-2 Invasion into the Central Nervous System.

Authors:  Maria Lima; Vasileios Siokas; Athina-Maria Aloizou; Ioannis Liampas; Alexios-Fotios A Mentis; Zisis Tsouris; Anastasios Papadimitriou; Panayiotis D Mitsias; Aristidis Tsatsakis; Dimitrios P Bogdanos; Stavros J Baloyannis; Efthimios Dardiotis
Journal:  Curr Treat Options Neurol       Date:  2020-09-25       Impact factor: 3.598

3.  Intraocular Pressure-Lowering Effect of Latanoprost Is Hampered by Defective Cervical Lymphatic Drainage.

Authors:  Young Kook Kim; Kyeong Ik Na; Jin Wook Jeoung; Ki Ho Park
Journal:  PLoS One       Date:  2017-01-12       Impact factor: 3.240

Review 4.  Neurological manifestations of patients with COVID-19: potential routes of SARS-CoV-2 neuroinvasion from the periphery to the brain.

Authors:  Zhengqian Li; Taotao Liu; Ning Yang; Dengyang Han; Xinning Mi; Yue Li; Kaixi Liu; Alain Vuylsteke; Hongbing Xiang; Xiangyang Guo
Journal:  Front Med       Date:  2020-05-04       Impact factor: 4.592

5.  Bleb-Independent Glaucoma Surgery to Activate the Uveolymphatic Route of Non-Trabecular Aqueous Humor Outflow: Short-Term Clinical and OCT Results.

Authors:  Vinod Kumar; Kamal Abdulmuhsen Abu Zaalan; Andrey Igorevich Bezzabotnov; Galina Nikolaevna Dushina; Ahmad Saleh Soliman Shradqa; Zarina Shaykuliyevna Rustamova; Mikhail Aleksandrovich Frolov
Journal:  Vision (Basel)       Date:  2022-01-12

Review 6.  Ocular Lymphatic and Glymphatic Systems: Implications for Retinal Health and Disease.

Authors:  Nasir Uddin; Matt Rutar
Journal:  Int J Mol Sci       Date:  2022-09-04       Impact factor: 6.208

Review 7.  Nanotechnology for Medical and Surgical Glaucoma Therapy-A Review.

Authors:  Marcelo Luís Occhiutto; Raul C Maranhão; Vital Paulino Costa; Anastasios G Konstas
Journal:  Adv Ther       Date:  2019-12-10       Impact factor: 3.845

8.  Eye lymphatic defects induced by bone morphogenetic protein 9 deficiency have no functional consequences on intraocular pressure.

Authors:  Mariela Subileau; Niyazi Acar; Alison Carret; Lionel Bretillon; Isabelle Vilgrain; Sabine Bailly; Daniel Vittet
Journal:  Sci Rep       Date:  2020-09-29       Impact factor: 4.379

9.  Systemic exposure following intravitreal administration of therapeutic agents: an integrated pharmacokinetic approach. 2. THR-687.

Authors:  Marc Vanhove; Jean-Marc Wagner; Bernard Noppen; Bart Jonckx; Elke Vermassen; Alan W Stitt
Journal:  J Pharmacokinet Pharmacodyn       Date:  2021-07-23       Impact factor: 2.745

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.